The global IVD quality control market size is expected to reach USD 1.24 billion by 2026,
according to a new report by Grand View Research, Inc. The market is projected
to witness a CAGR of 4.1% over the forecast period. Continually evolving
technology-oriented changes in the diagnostics field and growing need to ensure
patient safety necessitate the implementation of quality assurance programs in
various medical disciplines including radiology and Point-of-Care (PoC)
devices. Patients rely on self-testing IVD devices for long-term disease
management and hence it is important for such devices to be checked, in terms
of result reproducibility and validity, to guarantee patient safety.
Rising number of certified clinical
laboratories offering dependable IVD-based diagnostic services directly
correlates with increased patient confidence, thus driving the market. In
addition to quality assessments, amendments to the regulatory framework are
made intermittently to enhance the existing standards with the main objective
of safeguarding qualitative superiority of the diagnostic services. In May
2016, the European Union passed an agreement to update the pre-existing
regulations pertaining to IVD devices, wherein the updates were in concern with
raising the patient safety levels, particularly for disabled persons. The
presence of third-party agencies for independent assessment of the IVD devices
is expected to elevate the current safety standards, which will drive the In
Vitro Diagnostics (IVD) Quality Control market further.
Access Research Report of IVD Quality Control
Market@ https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market
Further key findings from the study suggest:
· In 2018, the clinical chemistry was the
second-largest application segment of the global IVD market, in terms of market
share
· Demand for preventive medicine and rapid
transformation of clinical laboratories into highly automated and efficient
businesses are some of the factors for the segment’s growth
· Molecular diagnostics is projected to be the
fastest-growing segment due to increasing technical complexity of molecular
diagnostic testing and need for quality evaluation to ensure standards
· These tests are of prime importance as the
outcomes enable healthcare practitioners make critical treatment decisions
· Hospitals was the largest segment in 2018
due to the presence of advanced technology-based devices like Next Generation
Sequencing (NGS) and microarrays, and rising applications of the optimized
quality-control procedures
· North America was the dominant regional
market in 2018 due to the presence of over 150,000 registered diagnostics labs
and is likely to maintain the dominance throughout the forecast years
· Siemens Healthcare GmbH; Roche Diagnostics;
Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories,
Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex
Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key
companies in the global market
Grand View Research has segmented the
global IVD quality control market on the basis of application, type, end use,
and region:
·
Immunochemistry
·
Hematology
·
Clinical Chemistry
·
Molecular Diagnostics
·
Coagulation
·
Microbiology
·
Others
IVD Quality Control Type Outlook
(Revenue, USD Million, 2014 - 2026)
·
Quality Control
o
Quality Controls, by Type
o
Plasma-based Control
o
Serum-based Control
o
Whole Blood-based Control
o
Others
o
Quality Controls, by Application
o
Immunochemistry
o
Hematology
o
Clinical Chemistry
o
Molecular Diagnostics
o
Coagulation
o
Microbiology
o
Others
·
Quality Assurance Services
o
Immunochemistry
o
Hematology
o
Clinical Chemistry
o
Molecular Diagnostics
o
Coagulation
o
Microbiology
o
Others
·
Data Management
o
Clinical Chemistry
o
Immunochemistry
o
Hematology
o
Molecular Diagnostics
o
Coagulation
o
Microbiology
o
Others
IVD Quality Control End Use Outlook
(Revenue, USD Million, 2014 - 2026)
·
Hospitals
·
Laboratories
·
Home-care
·
Others
IVD Quality Control Regional Outlook
(Revenue, USD Million, 2014 - 2026)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
o
France
o
Spain
o
Italy
o
Russia
·
Asia Pacific
o
Japan
o
China
o
India
o
South Korea
o
Singapore
o
Australia
·
Latin America
o
Brazil
o
Argentina
·
Middle East & Africa
o
South Africa
o
UAE
o
Saudi Arabia
Access Press Release of IVD Quality Control Market@ https://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-ivd-quality-control-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
